HomeTENX • NASDAQ
Tenax Therapeutics Inc
Follow
$5.80
3.33%
After Hours:(3.45%)+0.20
$6.00
Closed: Apr 4, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.29M | 118.34% |
Net income | -6.27M | -94.27% |
Net profit margin | — | — |
Earnings per share | -0.18 | 97.92% |
EBITDA | -7.29M | -118.62% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 94.85M | 868.66% |
Total assets | 96.69M | 727.44% |
Total liabilities | 4.69M | 30.83% |
Total equity | 91.99M | — |
Shares outstanding | 3.97M | — |
Price to book | 0.22 | — |
Return on assets | -18.56% | — |
Return on capital | -19.28% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.27M | -94.27% |
Cash from operations | -3.53M | -200.17% |
Cash from investing | — | — |
Cash from financing | 67.25K | 138.51% |
Net change in cash | -3.46M | -156.38% |
Free cash flow | -1.82M | -237.79% |
Previous close
$6.00
Day range
$5.67 - $6.25
Year range
$2.77 - $7.89
Market cap
23.03M USD
Avg Volume
35.88K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1967
Website
Employees
5
